Cotrimoxazole prophylaxis for infants exposed to HIV infection

Bulletin of the World Health Organization

Volumn 82, Issue 4, 2004, Pages 297-298

  Graham, Stephen M ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

DRUG PRESCRIBING; HUMAN IMMUNODEFICIENCY VIRUS;

BACTERIAL PNEUMONIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; NOTE; PNEUMOCYSTIS PNEUMONIA; PROPHYLAXIS;

AFRICA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; CHEMOPREVENTION; DISEASE TRANSMISSION, VERTICAL; HUMANS; INFANT; INFANT, NEWBORN; PNEUMONIA, PNEUMOCYSTIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 2342470542     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (12)

1. Grimwade K, Swingler, G. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV. Cochrane Database of Systematic Reviews 2003;3:CD003108.
2. Newell ML Ghent IAS working group on HIV infection in women and children. Mortality among infected and uninfected infants born to HIV-infected women in Africa: infants, HIV, and mortality in Africa study. 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, February 8-11, 2004 (Abstract 155).
3. Graham SM. HIV and respiratory infections in children. Current Opinions in Pulmonary Medicine 2003;9:215-20.
4. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet 1999;353:1469-75.
5. Anglaret X, Chene G, Attia A, Toure S, Lafont S, Combe P, et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet 1999;353:1463-8.
6. Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodefidency virus type 1-infected children. Clinical Infectious Diseases 2000;31:170-6.
7. Moraes-Pinto MI, Verhoeff F, Chimsuku L, Milligan PJ, Wesumperuma L, Broadhead RL, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Archive of Diseases of Child Fetal Neonatal Edition 1998;79:F202-F205.
8. Moraes-Pinto MI, Almeida AC, Kenj G, Filgueiras TE, Tobias W, Santos AM, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. Journal of Infectious Diseases 1996;173:1077-84.
9. Mulenga V, Gibb D, Bhat G, Walker A, Sinyiza F, Lishimpi K, et al. A randomized, placebo-controlled trial of cotrimoxazole as prophylaxis against opportunistic infections in children with HIV-1 infection in Zambia. 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, February 8-11, 2004 (Abstract 156LB).
10. Fisher RG, Nageswaran S, Valentine ME, McKinney RE, Jr. Successful prophylaxis against Pheumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole. AIDS Patient Care STDS. 2001;15:263-9.
11. Thirsk ER, Kapongo MC, Jeena PM, Liebeschuetz S, York DF, Vega G, et al. HIV-exposed infants with acute respiratory failure secondary to acute lower respiratory infections managed with and without mechanical ventilation. South African Medical Journal 2003;93:617-20.
12. Graham SM. Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa. Lancet 2002;360:1966-8.